Glomerular VEGF resistance induced by PKCδ/SHP‐1 activation and contribution to diabetic nephropathy
Akira Mima(Osaka University of Pharmaceutical Sciences), George L. King(Joslin Diabetes Center), Michael Leitges(Memorial University of Newfoundland), Christian Rask‐Madsen(University of Ulsan), Koji Mizutani(Nagoya University), Pedro Geraldes(Université de Sherbrooke), Qian Li(Shanghai Jiao Tong University), Weier Qi(Joslin Diabetes Center), Chenzhong Li(Joslin Diabetes Center), Motonobu Matsumoto(Joslin Diabetes Center), Munehiro Kitada(Kanazawa Medical University)
Cited by 102
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979